Maria Bruzelius

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Utvalda publikationer

Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2025;23(3):968-977
Out-of-hospital cardiac arrest associated with venous thromboembolism-a Swedish population-based cohort study
Bendz E; Oksanen A; Larsson S; Ohm J; Djarv T; Bruzelius M

Artiklar

Article: BLOOD ADVANCES. 2026;10(6):1854-1863
Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study
Mahlangu J; Boban A; Bruzelius M; Castaman G; Hampton K; Knoebl P; Lebreton A; Linari S; Lopez-Jaime F-J; Tavares CMM; Nekkal MS; Nogami K; Nielsen ARH; Shapiro A; D'Oiron R
Article: TH OPEN. 2025;09:a26469016
Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome-A Single-Centre Cohort Study
Karandyszowska N; Faustini F; Alagunduz H; Widaeus J; Carlens F; Jensen A-L; Oksanen A; Magnusson M; Gunnarsson I; Svenungsson E; Antovic A; Bruzelius M
Article: HAEMOPHILIA. 2025;31(3):450-457
Ratio of Von Willebrand Collagen Binding Assay and Von Willebrand Antigen Can Predict Multimer Size in Von Willebrand Disease
Kimiaei A; Pruner I; Farm M; Holmstrom M; Karandyszowska N; Bruzelius M; Antovic J; Agren A
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2025;23(3):937-946
High risk of long-term recurrence after a first episode of venous thromboembolism during pregnancy or postpartum: the REcurrence after a PrEgnAncy related Thrombosis (REPEAT) Study
Ibrahim-Kosta M; El Harake S; Leclercq B; De Mari C; Secondi J-F; Paoletti E; Suchon P; Benredouane Y; Brunet D; Barthet M-C; Bruzelius M; Munsch G; Tregouet D-A; Morange P-E; Goumidi L; Sarlon-Bartoli G
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2024;8(8):102611
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
Maseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Strandberg K; Tjonnfjord GE; Holme PA
Article: EJHAEM. 2024;5(4):768-771
Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-A case report
Boberg E; Kimiaei A; Karlstrom C; Ljungqvist M; Agren A; Bruzelius M
Article: THROMBOSIS AND HAEMOSTASIS. 2024;124(01):32-39
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B
Schmidt DE; Truedsson A; Stralfors A; Hojbjerg JA; Soutari N; Holmstrom M; Ranta S; Letelier A; Bowyer A; Ljung R; Antovic J; Bruzelius M
Article: HAEMOPHILIA. 2024;30(1):98-105
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
Maseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Tjonnfjord GE; Holme PA
Article: CLINICAL NUTRITION. 2023;42(8):1268-1275
Ultra-processed food intake and incident venous thromboembolism risk: Prospective cohort study
Yuan S; Chen J; Fu T; Li X; Bruzelius M; Akesson A; Larsson SC
Article: HAEMOPHILIA. 2023;29(4):987-996
No difference in quality of life between persons with severe haemophilia A and B
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Holme PA; Lassila R; Nummi V; Ranta S; Andersson NG; Berntorp E; Astermark J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;201(4):783-792
Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses
Yuan S; Titova OE; Zhang K; Gou W; Schillemans T; Natarajan P; Chen J; Li X; Akesson A; Bruzelius M; Klarin D; Damrauer SM; Larsson SC
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):99
Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design
Munsch G; Goumidi L; van Hylckama Vlieg A; Ibrahim-Kosta M; Bruzelius M; Deleuze J-F; Rosendaal FR; Jacqmin-Gadda H; Morange P-E; Tregouet D-A
Article: THROMBOSIS RESEARCH. 2022;217:22-32
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Holme PA; Lassila R; Martin M; Nummi V; Ranta S; Strandberg K; Andersson NG; Berntorp E; Astermark J
Article: NUTRIENTS. 2022;14(16):3354
Plasma Phospholipid Fatty Acids and Risk of Venous Thromboembolism: Mendelian Randomization Investigation
Yuan S; Li X; Morange P-E; Bruzelius M; Larsson SC
Article: PLOS ONE. 2022;17(7):e0270865
Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts
Smith P; Rosell A; Farm M; Bruzelius M; Gatica KA; Mackman N; Odeberg J; Thalin C
Article: CLINICAL NUTRITION. 2022;41(6):1191-1196
Anti-inflammatory diet and incident peripheral artery disease: Two prospective cohort studies
Yuan S; Bruzelius M; Damrauer SM; Hakansson N; Wolk A; Akesson A; Larsson SC
Article: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2022;53(1):43-50
Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation
Yuan S; Bruzelius M; Larsson SC
Article: RESUSCITATION PLUS. 2021;8:100178
In-hospital cardiac arrest due to pulmonary embolism - Treatment and outcomes in a Swedish cohort study
Henriksson CE; Frithiofsson J; Bruchfeld S; Bendz E; Bruzelius M; Djarv T
Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(12):1610-1621
Platelet Count Rose While D-Dimer Levels Dropped as Deaths and Thrombosis Declined-An Observational Study on Anticoagulation Shift in COVID-19
Sjostrom A; Wersall JD; Warnqvist A; Farm M; Magnusson M; Oldner A; Agren A; Antovic J; Bruzelius M
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021;10(21):e022286
Cardiometabolic, Lifestyle, and Nutritional Factors in Relation to Varicose Veins: A Mendelian Randomization Study
Yuan S; Bruzelius M; Damrauer SM; Larsson SC
Visa fler

Alla övriga publikationer

Letter: RHEUMATOLOGY. 2024;63(12):e339-e340
Eculizumab and ravulizumab in the treatment of refractory antiphospholipid syndrome-a first case report
Antovic A; Faustini F; Karandyszowska N; Svenungsson E; Yilmaz EB; Bruzelius M; Gunnarsson I
Conference publication: HAEMOPHILIA. 2024;30:23-24
Efficacy and safety of concizumab prophylaxis in haemophilia A or B with and without inhibitors: 56-week cut-off results of the phase 3 explorer7 and explorer8 studies
Windyga J; Apte S; Astermark J; Bruzelius M; Castaman G; Eichler H; Hampton K; Hansen T; Knoebl P; Lebreton A; Linari S; Lyu CJ; Mathias M; Nielsen ARH; Poulsen LH; Trakymiene SS; Tran H; Zaw JJT; d'Oiron R
Letter: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023;61(12):e248-e250
Laboratory response to paradigm change in hemophilia treatment How to monitor patients simultaneously treated with emicizumab and factor VIII concentrate?
Lambert MS; Bruzelius M; Soutari NMH; Ranta S; Antovic JPP
Preprint: MEDRXIV. 2021
Modelling of time-to-events in an ambispective study: illustration with the analysis of ABO blood groups on venous thrombosis recurrence
Munsch G; Goumidi L; van Hylckama Vlieg A; Ibrahim-Kosta M; Bruzelius M; Deleuze J-F; Rosendaal FR; Jacqmin-Gadda H; Morange P-E; Trégouët D-A
Book chapter: LECTURE NOTES IN COMPUTER SCIENCE. 2021;p. 108-121
Explainable Artificial Neural Network for Recurrent Venous Thromboembolism Based on Plasma Proteomics
Razzaq M; Goumidi L; Iglesias M-J; Muns G; Bruzelius M; Ibrahim-Kosta M; Butler L; Odeberg J; Morange P-E; Tregouet DA
Doctoral thesis: 2015
Exploration of novel mechanisms and biomarkers for venous thromboembolism : a genetics and proteomics study
Bruzelius M
Book chapter: ESSENTIAL GUIDE TO BLOOD COAGULATION. 2013;p. 56-61
Critical bleeding
Bruzelius M; Ågren A; Johnsson H
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2012;10(8):1693-1695
Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis
Tregouet D-A; Sabater-Lleal M; Bruzelius M; Emmerich J; Amouyel P; Dartigues J-F; Kieler H; Morange P-E

Forskningsbidrag

Increased risk for thrombotic complications in patients with rheumatic diseases -from register data to individual patient and biomarkers
Stockholm County Council and Karolinska Institutet (ALF)
1 januari 2024 - 31 december 2025

Anställningar

Anknuten Till Forskning, K2 Medicin, Solna, Karolinska Institutet, 2023-
Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026
Clinical Post Doctor, Karolinska Instutet/Region Stockholm, 2018-2021

Examina och utbildning

Docent, Associated Professor, Internmedicin, Medicin, Solna, Karolinska Institutet, 2023
Doctor of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2015
Specialist in Coagulation and bleeding disorders, National Board of Health and Welfare, 2009
Specialist in Internal Medicine, National Board of Health and Welfare, 2006
Doctor of Medicine, Lund University, 1998

Handledning

Handledning till doktorsexamen
- Shuai Yuan, Modifiable Risk Factors, Blood Proteins and Venous Thromboembolism, 2024
- Anna Sjöström, Severe COVID-19 and routine biomarker pattern, 2023
- Emma Bendz, Pulmonary embolism as the cause of out of hospital cardiac arrest in women - A Swedish population-based register study, 2021-
- Natali Karandyszowska, Diagnostic and therapeutic challenges in patients with antiphospholipid syndrome, 2021-

Utvalda publikationer

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Handledning

Handledning till doktorsexamen

Utvärdering av avhandlingsarbete

Nyheter från KI

Kalenderhändelser från KI